Feasibility Analysis of the Parametric Response Map as an Early Predictor of Treatment Efficacy in Head and Neck Cancer

REFERENCES

1. 1.↵
   2. Siegel R,
   3. Naishadham D,
   4. Jemal A

   . Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Ferlay J,
   3. Shin HR,
   4. Bray F, et al

   . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Crozier E,
   3. Sumer BD

   . Head and neck cancer. Med Clin North Am 2010;94:1031–46

   CrossRefPubMed
4. 4.↵
   2. Cohan DM,
   3. Popat S,
   4. Kaplan SE, et al

   . Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 2009;17:88–94

   CrossRefPubMed
5. 5.↵
   2. Lin DT,
   3. Cohen SM,
   4. Coppit GL, et al

   . Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngol Clin North Am 2005;38:59–74, viii

   CrossRefPubMed
6. 6.↵
   2. Osborne RF,
   3. Brown JJ

   . Carcinoma of the oral pharynx: an analysis of subsite treatment heterogeneity. Surg Oncol Clin N Am 2004;13:71–80

   CrossRefPubMed
7. 7.↵
   American Cancer Society. Cancer Facts & Figures 2010. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/index. Accessed February 3, 2014.
8. 8.↵
   2. Jemal A,
   3. Siegel R,
   4. Xu J, et al

   . Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Monnerat C,
   3. Faivre S,
   4. Temam S, et al

   . End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 2002;13:995–1006

   Abstract/FREE Full Text
10. 10.↵
    2. Hermans R

    . Post-treatment imaging of head and neck cancer. Cancer Imaging 2004;4(Spec No A):S6-15

    CrossRefPubMed
11. 11.↵
    2. Cao Y

    . The promise of dynamic contrast-enhanced imaging in radiation therapy. Semin Radiat Oncol 2011;21:147–56

    CrossRefPubMed
12. 12.↵
    2. Hamstra DA,
    3. Chenevert TL,
    4. Moffat BA, et al

    . Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 2005;102:16759–64

    Abstract/FREE Full Text
13. 13.↵
    2. Moffat BA,
    3. Chenevert TL,
    4. Lawrence TS, et al

    . Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005;102:5524–29

    Abstract/FREE Full Text
14. 14.↵
    2. Galbán CJ,
    3. Mukherji SK,
    4. Chenevert TL, et al

    . A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2:184–90

    CrossRefPubMed
15. 15.↵
    2. Srinivasan A,
    3. Chenevert TL,
    4. Dwamena BA, et al

    . Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma. J Comput Assist Tomogr 2012;36:131–37

    CrossRefPubMed
16. 16.↵
    2. Tofts PS,
    3. Brix G,
    4. Buckley DL, et al

    . Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Galbán CJ,
    3. Chenevert TL,
    4. Meyer CR, et al

    . The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med 2009;15:572–76

    CrossRefPubMed
18. 18.↵
    2. Tsien C,
    3. Galbán CJ,
    4. Chenevert TL, et al

    . Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol 2010;28:2293–99

    Abstract/FREE Full Text
19. 19.↵
    2. Wang P,
    3. Popovtzer A,
    4. Eisbruch A, et al

    . An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer. Med Phys 2012;39:5277–85

    CrossRefPubMed
20. 20.↵
    2. Lavini C,
    3. Verhoeff JJ

    . Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn Reson Imaging 2010;28:1420–30

    CrossRefPubMed